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Abstract
Background: Thoroughbred horses have been selected for traits contributing to speed and stamina for centuries.
It is widely recognized that inherited variation in physical and physiological characteristics is responsible for
variation in individual aptitude for race distance, and that muscle phenotypes in particular are important.
Results: A genome-wide SNP-association study for optimum racing distance was performed using the EquineSNP50
Bead Chip genotyping array in a cohort of n = 118 elite Thoroughbred racehorses divergent for race distance
aptitude. In a cohort-based association test we evaluated genotypic variation at 40,977 SNPs between horses suited
to short distance (≤8 f) and middle-long distance (>8 f) races. The most significant SNP was located on chromosome
18: BIEC2-417495 ~690 kb from the gene encoding myostatin (MSTN)[ Punadj. = 6.96 × 10
-6]. Considering best race
distance as a quantitative phenotype, a peak of association on chromosome 18 (chr18:65809482-67545806)
comprising eight SNPs encompassing a 1.7 Mb region was observed. Again, similar to the cohort-based analysis, the
most significant SNP was BIEC2-417495 (Punadj. = 1.61 × 10
-9; PBonf. = 6.58 × 10
-5). In a candidate gene study we have
previously reported a SNP (g.66493737C>T) in MSTN associated with best race distance in Thoroughbreds; however,
its functional and genome-wide relevance were uncertain. Additional re-sequencing in the flanking regions of the
MSTN gene revealed four novel 3’ UTR SNPs and a 227 bp SINE insertion polymorphism in the 5’ UTR promoter
sequence. Linkage disequilibrium was highest between g.66493737C>T and BIEC2-417495 (r
2 = 0.86).
Conclusions: Comparative association tests consistently demonstrated the g.66493737C>T SNP as the superior
variant in the prediction of distance aptitude in racehorses (g.66493737C>T, P = 1.02 × 10
-10; BIEC2-417495, Punadj. =
1.61 × 10
-9). Functional investigations will be required to determine whether this polymorphism affects putative
transcription-factor binding and gives rise to variation in gene and protein expression. Nonetheless, this study
demonstrates that the g.66493737C>T SNP provides the most powerful genetic marker for prediction of race
distance aptitude in Thoroughbreds.
Background
Thoroughbred horses have been selected for structural and
functional variation contributing to speed and stamina dur-
ing the three century development of the breed. The Inter-
national Federation of Horseracing Authorities recognizes
five distance categories: Sprint (5-6.5 furlongs [f],
≤ 1,300 m), Mile (6.51-9.49 f, 1,301-1,900 m), Intermediate
(9.5-10.5 f, 1,901-2,112 m), Long (10.51-13.5 f, 2,114-2,716
m) and Extended (> 13.51 f, > 2,717 m) races (http://www.
horseracingintfed.com) and it is widely recognized among
horse breeders that variation in physical and physiological
characteristics are responsible for variation in individual
aptitude for race distance [1]. Although environment and
training may contribute to the race distance for which a
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any medium, provided the original work is properly cited.horse is best suited, the genetic contribution to the ability
to perform optimally at certain distances is large; the herit-
ability of best distance among Australian racehorses has
been estimated as 0.94 ± 0.03 [2].
A principal characteristic contributing to the ability of
a Thoroughbred to perform well in short distance,
sprint races is the extent and maturity of the skeletal
musculature. Sprinters are generally shorter, stockier
animals with greater muscle mass than animals suited to
endurance performance, and generally mature earlier.
Performance aptitude for speed and stamina has also
been associated with muscle fibre type phenotypes [3,4]
and metabolic adaptations to training [5]. Variation in
cardiovascular function contributing to aerobic capacity
may also play a role in distinguishing individuals suited
to shorter or longer distance races.
We have previously reported a sequence polymorph-
ism (g.66493737C>T) in the equine myostatin (MSTN)
gene strongly associated (P=4.85 × 10
-8) with optimum
racing distance in Thoroughbred racehorses [6]. In sev-
eral mammalian species, including cattle, sheep, dogs
and horses, muscle hypertrophy phenotypes are asso-
ciated with sequence variants in the MSTN gene [7-11].
Among horses that compete preferably in short distance
(≤7 f) races requiring exceptional speed, the C allele is
twice as common than among horses that perform opti-
mally in longer distance (>8 f) races that require more
stamina (0.72 and 0.36 respectively). On average the
optimum racing distance for C:C horses was 6.2 ± 0.8 f,
for C:T horses was 9.1 ± 2.4 f and for T:T horses was
10.5 ± 2.7 f. Furthermore, C:C horses have significantly
greater muscle mass than T:T horses at two-years-old.
Skeletal muscle phenotypes clearly play a role in distin-
guishing distance aptitude, and there is a strong effect of
MSTN genotype on distance [6]. However, heretofore, the
effects of additional nuclear gene variants that may contri-
bute to equine performance-related phenotypes have not
been investigated. Therefore, we performed a genome-
wide SNP-association study using the EquineSNP50 Bead
Chip genotyping array in a cohort of elite race winning
Thoroughbred horses. Animals were separated into two
distinct phenotypic cohorts comprising short distance
(≤8 f) and middle-long distance (>8 f) race winners and
genetic associations were evaluated using best race dis-
tance as a quantitative phenotype. This study was designed
to identify additional genetic loci as indicators of race
distance aptitude and to establish whether variation at
the g.66493737C>T SNP was associated with inter-locus
epistatic effects for race distance performance.
Methods
Ethics
This work has been approved by the University College
Dublin, Ireland, Animal Research Ethics Committee.
Study animals and cohorts
A repository of registered Thoroughbred horse blood or
hair samples (n > 1,400) was collected from stud farms,
racing yards and sales establishments in Ireland, Great
Britain and New Zealand during 1997 to 2008. Each
sample was categorized based on retrospective race-
course performance records. Only horses with perfor-
mance records in Flat races were included in the study.
The study cohort comprised elite Thoroughbreds that
h a dw o na tl e a s to n eG r o u pr a c e( G r o u p1 ,G r o u p2o r
Group 3) or a Listed race–the highest standard and
most valuable elite Flat races are known as Group
(Stakes) races and Listed races are the next in status.
Only elite race winning horses were included as elite
races are most likely to reflect the truest test for dis-
tance. Race records were derived from three sources
[Europe race records: The Racing Post on-line database
http://www.racingpost.co.uk; Australasia and South East
Asia race records: Arion Pedigrees http://www.arion.co.
nz; North America race records: Pedigree Online Thor-
oughbred database http://www.pedigreequery.com].
Each sample was assigned a best race distance which
was defined as the distance (furlongs, f) of the highest
grade of race won [note: 1 furlong = 1/8 mile = 201.2
meters]. When multiple races of the same grade were
won, then the distance of the most valuable race, in
terms of prize money, was used. A set of elite Thor-
oughbred samples (n = 118) was selected from the repo-
sitory, mostly comprising samples procured in Ireland
and Great Britain (i.e. n = 5 samples [n =3≤ 8f ,n =2
>8 f] were collected in New Zealand); though some had
won their best race in North America. Animals with
excessive consanguinity (within two generations) were
avoided and over-representation of popular sires within
the pedigrees was minimized as far as possible. One
hundred and seven sires were represented in the total
sample set. Genomic DNA was extracted from either
fresh whole blood or hair samples using a modified ver-
sion of a standard phenol/chloroform method [12] or
the Maxwell 16 automated DNA purification system
(Promega, WI, USA). DNA samples were quantified
using Quant-iT PicoGreen dsDNA kits (Invitrogen,
Carlsbad, CA) according to the manufacturer’si n s t r u c -
tions and the DNA concentrations were adjusted to
20 ng/μl.
For the case-control investigation we compared two
cohorts: samples were subdivided into short (≤ 8f ,n =
68) and middle-long (> 8 f, n = 50) distance elite race
winning cohorts (Table 1).
Genotyping and quality control
Samples were genotyped using EquineSNP50 Genotyp-
ing BeadChips (Illumina, San Diego, CA). This array
contains approximately 54,000 SNPs ascertained from
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and has an average density of one SNP per 43.2 kb.
Genotyping was performed by AROS Applied Biotech-
nology AS, Denmark. The samples that were genotyped
for this study were a subset of n =1 8 7s a m p l e sg e n o -
typed in two separate batches (Batch 1, n = 96; Batch 2,
n = 91). We included four pairs of duplicate samples in
Batch 2 for QC purposes and observed greater than
99.9% concordance in the four pairs. In total, we suc-
cessfully genotyped 53,795 loci. All samples had a geno-
typing rate of greater than 90%. We omitted SNPs
which had a genotyping completion rate of less than
90%, were monomorphic or had minor allele frequencies
(MAF) less than 5% in our samples from further analy-
sis. We omitted 12,818 SNPs leaving 40,977 SNPs in
our working build of the data and the overall genotype
completion rate was 99.8%.
Statistical analyses
All statistical analyses, including tests of association
were performed using PLINK Version 1.05 [14]. We
compared genotype frequencies in short and middle-
long distance cohorts, testing for trait association using
c
2 tests with two degrees of freedom. To test for popu-
lation stratification, the pairwise identity-by-state (IBS)
distance was calculated for all individuals. A permuta-
tion test was performed to investigate IBS differences
among the short and middle-long distance cohorts. The
linear regression model was used to evaluate quantita-
tive trait association using best race distance (f) as the
phenotype. We report uncorrected P-values (Punadj.) and
P-values following correction for multiple testing using
the Bonferroni method (PBonf.). Manhattan and Q-Q
plots were generated in R using a modified version of
code. The regional association plot was generated in R
using a modified version of code available at http://
www.broadinstitute.org.
Cohort-based association (short vs middle-long dis-
tance) and quantitative trait association tests were also
performed for the g.66493737C>T SNP [6] and a novel
5’UTR MSTN SINE insertion (Ins227bp) polymorphism
identified in this study. In addition, an analysis of gen-
ome-wide epistasis was performed in which the
g.66493737C>T SNP was tested against all SNPs on the
EquineSNP50 Genotyping BeadChip for epistatic inter-
actions influencing best race distance. This test involved
a linear regression analysis to investigate whether gene
by gene interactions had a significant influence on
best race distance. Linkage disequilibrium (LD) bet-
ween g.66493737C>T and Ins227bp and between
g.66493737C>T and all chromosome 18 SNPs on the
EquineSNP50 Genotyping BeadChip was quantified
as r
2. A visual representation of haplotype blocks across
a 1.7 Mb region on chromosome 18 was generated
using Haploview [15,16].
Re-sequencing MSTN flanking sequences
PCR primers were designed to cover ~2 kb of the
5’UTR and ~2 kb of the 3’ UTR of MSTN genomic
sequence using the PCR Suite extension to the Primer3
web-based primer design tool [17,18] (Table S1). Fifteen
unrelated Thoroughbred DNA samples (g.66493737C>T,
n = 5 C:C; n = 5 C:T, n = 5 T:T) were included in a re-
sequencing panel to identify novel sequence variants.
Bidirectional DNA sequencing of PCR products was
performed by Macrogen Inc. (Seoul, Korea) using AB
3730xl sequencers (Applied Biosystems, Foster City,
CA). Sequence variants were detected by visual exami-
nation of sequences following alignment using Consed
version 19.0 [19].
Bioinformatics
The software tool MatInspector [20] was used to search
for transcription factor binding site consensus sequences
present in 300 bp of the MSTN 5’ UTR region in which
a novel SINE insertion (Ins227bp) polymorphism was
detected. To investigate possible microRNA (miRNA)
regulation of MSTN gene expression we screened the
equine MSTN gene and flanking sequences for putative
miRNA binding sites. A list of 407 predicted equine
miRNAs [21] were inputted into the online tool DIANA
microtest http://diana.pcbi.upenn.edu/cgi-bin/micro_t.
cgi and a 14.7 kb segment containing the equine MSTN
gene and ~5 kb of upstream and downstream sequence
was inputted as the target sequence. SNPInspector [20]
was used to investigate transcription factor binding sites
at the g.66493737C>T locus.
Genotyping the Chr18g.66495327Ins227bp66495326
(Ins227bp) polymorphism
A PCR-based assay for allele size discrimination was
used to genotype the Ins227bp polymorphism in n =
Table 1 Description of phenotype cohorts
N No. sires Mean RPR Range RPR Mean BRD Range BRD
All TBs 118 107 116 84-138 8.6 5-16
Short (≤ 8 f) 68 63 114 84-129 6.8 5-8
Middle-long (>8 f) 50 48 120 107-138 11.3 9-16
All TBs (Thoroughbreds) were used for the quantitative association test analysis. Racing Post Ratings (RPR) represent handicap ratings (best lifetime RPR) that are
indicative of performance ability. Best race distance (BRD) was the distance (f) of the highest grade of race (Group 1, 2, 3, Listed) won.
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5’-ATCAGCTCACCCTTGACTGTAAC-3’ and reverse
5’-TCATCTCTCTGGACATCGTACTG-3’. Alleles were
determined as follows: Normal allele - 600 bp; and
Insertion227bp allele - 827 bp.
Results
Genome-wide SNP-association study
In a cohort-based genotype-phenotype investigation we
compared two cohorts: short (≤8f )a n dm i d d l e - l o n g
(>8 f) distance elite race winners. The GWAS results,
sorted by chromosome, are shown in Figure 1. The
most significant SNP was on chromosome 18 (BIEC2-
417495, Punadj. =6 . 9 6×1 0
-6) and five of the top ten
SNPs were located together spanning a 2.4 Mb region
on chromosome 18 (chr18:64725066-67186093). How-
ever, no SNP in this analysis reached genome-wide sig-
nificance following correction for multiple-testing.
Pairwise IBS values were used to investigate popula-
tion stratification between the short and middle-long
cohorts. While on average phenotypically concordant
pairs of individuals were more similar than phenotypi-
cally discordant pairs (P = 0.034), the overall difference
between the two groups was negligible (< 0.0002).
Using the linear regression model, we considered best
race distance as a quantitative phenotype and observed
the same peak of association on chromosome 18
(chr18:65809482-67545806) (Figure 2; Additional File 1).
The top eight SNPs encompassed a 1.7 Mb region on
chromosome 18 (Figure 3) and seven reached genome-
wide significance following correction for multiple testing
(PBonf. < 0.05). The most significant SNP was also the
most significant in the cohort-based analysis: BIEC2-
417495 (Punadj. = 1.61 × 10
-9; PBonf. = 6.58 × 10
-5).
Candidate performance-associated genes
We investigated candidate genes in the 1.7 Mb
(Chr18:65809482-67545806) region on chromosome 18
that encompassed the seven SNPs that reached genome-
wide significance. Eleven protein coding genes were
Figure 1 Manhattan plot of P-value for genotype-phenotype GWAS in short (≤ 8 f) and middle-long (> 8 f) distance elite race winners.
The y-axis plots -log10(P-values) and the x-axis plots the physical position of the SNPs sorted by chromosome and chromosome position. The
most significant SNP was on chromosome 18 (BIEC2-417495). No SNP remained statistically significant following correction for multiple-testing.
Hill et al. BMC Genomics 2010, 11:552
http://www.biomedcentral.com/1471-2164/11/552
Page 5 of 10identified, including the myostatin gene (MSTN) and the
NGFI-A binding protein 1 (EGR1 binding protein 1)
gene (NAB1).
Polymorphism detection in equine MSTN flanking
sequences
We previously identified SNPs in intron 1 of the equine
MSTN gene by re-sequencing the coding and intronic
sequence [6]. However, genomic sequence or structural
variation in the flanking regions was not investigated.
Therefore, for the present study we re-sequenced 2,251 bp
(chr18:66494683-66496834) of the 5’ UTR and 2,155 bp
(chr18:66488052-66490207) of the 3’ UTR of the MSTN
gene (Additional File 2) and identified four novel SNPs in
the 3’ UTR and a SINE insertion polymorphism in the
5’ UTR. An overview of sequence and structural variation
in the equine MSTN gene and flanking sequences is pro-
vided in Additional File 3.
Polymorphisms in the 3’ UTR of the MSTN gene have
been associated with muscle hypertrophy in sheep and
are considered likely to function via creation of de novo
target sites for the microRNAs (miRNA) miR-1 and
miR-206 [22]. Therefore, using a set of equine miRNAs
(n = 407) described by Zhou and colleagues [21] we
investigated the presence of putative miRNA binding
sites within ~5 kb upstream and downstream flanking
sequences of the MSTN gene. Five putative miRNA
binding sites were identified, though none was poly-
morphic: i.e. no putative miRNA binding site was asso-
ciated with any of the eight SNP alleles.
Following re-sequencing in the 5’ UTR region of the
MSTN gene, we identified a 227 bp insertion polymorph-
ism at chr18:66495327-[Insertion227bp]-66495326 (hence-
forth referred to as Ins227bp), located 146 bp from the
start of exon 1 (Exon1Start: 66495180). The insertion
sequence is as follows:
Figure 2 Manhattan plot of P-value for quantitative trait GWAS using best race distance as phenotype. The y-axis plots -log10(P-values)
and the x-axis plots the physical position of the SNPs sorted by chromosome and chromosome position. A peak of association on chromosome
18 (chr18:65809482-67545806) encompassed a ~1.7 Mb region (shown in Figure 3). Seven of the chromosome 18 SNPs remained significant
following correction for multiple testing. The most significant SNP was BIEC2-417495 (PBonf. =6 . 5 8×1 0
-5).
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CTCCGCTGCAGGCGGCCCAGTGTTTCGTCGGTTCGAGTC
CTGGGCGCGGACATGGCACTG
CTCGTCGGACCACGCTGAGGCAGCGTCCCACATGCCA
CAACTAGAGGAACCCACAACGAAGAATACACAACTATGT
ACCGGGGGGCTTTGGGGAGAA
AAAGGAAAATAAAATCTTTAAAAAGCCACTTGG.
A BLAST search identified the insertion sequence as a
horse-specific repetitive DNA sequence element (SINE)
known as ERE-1 [23]. Also, MatInspector analysis indi-
cated that the insertion may disrupt an E-box motif.
In 14 of the 15 sequenced samples, the Ins227bp allele
was in concordance with the C-allele at g.66493737C>T.
As complete concordance was not observed, we geno-
typed a set of n = 165 samples to determine the extent of
concordance between the Ins227bp and g.66493737C>T
polymorphisms. We performed parallel association tests
for the same set of samples to evaluate the relative per-
formance of the two polymor p h i s m sa sp r e d i c t o r so f
optimum racing distance. The g.66493737C>T SNP per-
formed better in an association test with best race dis-
tance (P = 5.24 × 10
-13) than the Ins227bp polymorphism
(P =5 . 5 4×1 0
-10). Analysis of the sequence surrounding
g.66493737C>T indicated that alternate alleles may result
in the gain of a putative Homeobox C8/Hox-3alpha tran-
scription factor binding site and/or the disruption of
putative Distal-less homeobox 3, E2F and Pdx1 transcrip-
tion factor binding sites.
Linkage disequilibrium
Pairwise tests of linkage disequilibrium (LD) were per-
formed between g.66493737C>T and Ins227bp, and
between g.66493737C>T and the 1,373 chromosome 18
SNPs represented on the genotyping array. LD was high-
est between g.66493737C>T and BIEC2-417495 (r
2 =
0.86). LD between g.66493737C>T and Ins227bp was
r
2 = 0.73. Seven discrete haplotype blocks were identified
in the 1.7 Mb peak of association on chromosome 18.
The g.66493737C>T SNP was included in block 3;
BIEC2-417495 was included in block 6 (Figure 4).
Discussion
We have previously described an association between
optimum racing distance and a SNP (g.66493737C>T)
in the equine MSTN gene in Thoroughbred Flat race-
horses [6]. Candidate gene approaches are designed con-
sidering ap r i o r ihypotheses and do not allow the
opportunity for evaluation of the effect of the gene in
the context of the entire genome, nor do they allow for
the identification of other genes contributing to the phe-
notype [24,25]. Therefore, employing a hypothesis-free
approach we investigated genome-wide influences on
optimum racing distance by conducting a genome-wide
SNP-association study in a cohort of elite Thoroughbred
racehorses.
The genomic region on chromosome 18 containing
the MSTN gene was the highest ranked region in the
Figure 3 A regional plot for the 1.8 Mb peak of association on chromosome 18 containing the MSTN and NAB1 genes. Association plot
of the 1.8 Mb region encompassing 40 SNPs (diamonds) and the Ins227bp polymorphism (circle) ranging from one SNP upstream and one SNP
downstream of the seven SNPs significantly associated with optimum racing distance following correction for multiple testing. The y-axes plot
-log10(P-values) for each SNP (diamonds) and r
2 (blue line) between g.66493737C>T and all other SNPs. The x-axis plots the physical position of
each SNP in the region. The best SNP, g.66493737C>T, is indicated with a blue diamond. Each SNP is color coded according to the strength of
LD with g.66493737C>T: r
2 ≥ 0.8, red; r
2 ≥ 0.5 < 0.8, orange; r
2 ≥ 0.2 < 0.5, yellow; r
2 < 0.2, white.
Hill et al. BMC Genomics 2010, 11:552
http://www.biomedcentral.com/1471-2164/11/552
Page 7 of 10GWAS for best racing distance, reaching genome-wide
significance for a set of seven SNPs within a 1.7 Mb
region. The best SNP (BIEC2-417495) and the second
best SNP (BIEC2-417372) were 692 kb and 28 kb from
the MSTN gene, respectively. We searched the region
for other plausible candidate genes and identified the
NGFI-A binding protein 1 (EGR1 binding protein 1)
gene (NAB1) located ~170 kb from BIEC2-417495. The
product of the NAB1 gene is highly expressed in cardiac
muscle and has been reported to be a transcriptional
regulator of cardiac growth [26]. Its principal role is in
its interaction with the early growth response 1 (EGR-1)
transcriptional activator that is involved in regulation of
cellular growth and differentiation [27].
We considered NAB1 as a strong candidate gene to
influence an athletic performance phenotype as we have
previously identified EGR-1 mRNA transcript alterations
(+1.6-fold, P=0.014) in skeletal muscle immediately fol-
lowing a bout of treadmill exercise in untrained Thor-
oughbred horses [28]. Twelve SNPs located within the
NAB1 genomic sequence (chr18:g.66995249-67021729)
are documented in the EquCab2 SNP database, and
three are contained on the EquineSNP50 Genotyping
BeadChip. After correction for multiple testing, there
were no detectable associations between the three NAB1
SNPs and the trait (BIEC2-417453, Punadj. = 0.0007, rank
144; BIEC2-417454, Punadj. = 0.0012, rank 210; and
BIEC2-417458, Punadj. = 0.0032, rank 421). Therefore,
we did not further consider NAB1 as a potential major
contributor to variation in optimum racing distance.
Results from analyses of gene expression generated
since our initial report of an association between MSTN
genomic variation and optimum racing distance in
Thoroughbreds support the hypothesis that the MSTN
gene is functionally relevant to racing performance var-
iation. In a transcriptome-wide investigation using digi-
tal gene expression (DGE) technology, we identified the
greatest alteration in mRNA abundance in transcripts
from MSTN in Thoroughbred skeletal muscle following
a ten-month period of exercise training. Seventy-four
annotated transcripts were differentially expressed
between pre-and post-training states and among the 58
genes with decreased expression, MSTN mRNA tran-
scripts were the most significantly reduced (-4.2-fold,
P = 0.0043) [29].
Consequently, we focused on comprehensively evalu-
ating variation in the MSTN gene by re-sequencing ~2
kb of the 3’ and 5’ flanking sequences. Four novel 3’
UTR SNPs and a 227 bp SINE insertion (Ins227bp)
polymorphism located 146 bp upstream of the coding
region start site were identified. We investigated
whether the 3’ UTR SNPs may abrogate existing or cre-
ate de novo putative miRNA binding sites, as has been
described for MSTN influenced phenotypic variation in
Texel sheep [22]. However, there was no evidence for
alterations in putative miRNA binding sites. Next,
because of the close proximity to the transcriptional
start site, we considered the Ins227bp polymorphism as
a strong functional candidate contributing to variation
in racing performance. However, a comparative evalua-
tion of association using the same set of samples (n =
165) demonstrated that the g.66493737C>T SNP dis-
played a stronger association (P=5.24 × 10
-13)w i t h
best race distance than the Ins227bp polymorphism
(P = 5.54 × 10
-10).
An evaluation of LD showed that the strongest associa-
tion was between g.66493737C>T and the most significant
SNP in the present study, BIEC2-417495. A comparison of
trait association in the same set of samples (n =1 1 8 )
confirmed the superior power of the g.66493737C>T SNP
(P=1.02 × 10
-10) in the prediction of best race distance
when compared with BIEC2-417495 (Punadj. = 1.61 × 10
-9).
The significance values and genotype frequencies for the
top SNPs in the GWAS and the g.66493737C>T SNP are
Figure 4 A visual representation of haplotype blocks across a 1.7 Mb region on chromosome 18. The g.66493737C>T SNP was included
in block 3; BIEC2-417495 was included in block 6.
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g.66493737C>T may interact with other SNPs represented
on the EquineSNP50 genotyping array; however, no signif-
icant interaction was observed to influence best race dis-
tance (P > 0.0001 for all interactions). Therefore, the effect
of genotype on racing phenotype is highly likely a result of
the previously reported variation in the MSTN gene at
locus g.66493737C>T.
It is important to note that the sample size used for the
present study is relatively small. However, the results of
the quantitative trait GWAS demonstrate that the sample
size used was sufficient to detect a major genetic effect
such as that manifested at the MSTN locus. A lower sam-
p l es i z er e q u i r e m e n tf o rG W A Si nt h eT h o r o u g h b r e di s
supported by population genomics analyses of this popu-
lation in comparison to other horse breeds. These
demonstrate that the extent of LD in the Thoroughbred
is significantly greater than that measured in other horse
populations, being comparable to LD estimates in inbred
dog breeds [13].The high LD in Thoroughbreds is a
reflection of low effective population size, which enables
detection of associations with smaller sample sizes.
The mechanism by which the g.66493737C>T sequence
variant may affect the muscle phenotype in horses is not
clear; however we propose a direct effect of the SNP on
the control of myocyte development. Myostatin is a
growth and differentiation factor (GDF8) that functions as
a negative regulator of skeletal muscle mass development
and results in hypertrophied muscle phenotypes in a range
of mammalian species, including horse. Consistent with
this role myostatin has been shown to repress the prolif-
eration and differentiation of cultured myocytes [30-32].
The proliferation of myoblasts is determined by the con-
trol and progression of the cell cycle, a role which has
been assigned to members of the E2F family of transcrip-
tion factors [33]. The g.66493737C>T SNP is located
within the sequence of a putative E2F transcription factor
binding site in intron 1 of the MSTN gene. It may there-
fore be plausible to propose a mechanism by which allele-
specific binding of E2F to myostatin influences the growth
and development of myocytes following signalling from
upstream effector proteins such as retinoblastoma protein
[34]. Genotype-specific gene expression studies will shed
light on the allele-specific effect on function.
Conclusion
This study represents the first genome-wide investiga-
tion of sequence variant association with an athletic per-
formance phenotype in Thoroughbred racehorses. It
complements a recent DGE transcriptome-wide investi-
gation of functional responses to exercise training in
Thoroughbred skeletal muscle, which identified MSTN
mRNA transcripts as the most significantly altered fol-
lowing a ten month period of training. The present
study provides clear evidence that the previously
reported polymorphism in equine MSTN at locus
g.66493737C>T is the most powerful genome-wide pre-
dictor of optimum racing distance in Thoroughbred
horses.
Additional material
Additional file 1: Quantitative association test results for best race
distance. Unadjusted and FDR corrected P-values are given.
Additional file 2: PCR and sequencing primers for re-sequencing
MSTN flanking regions. Primers were designed to cover ~2 kb of the 3’
UTR and ~2 kb of the 5’ UTR of the MSTN gene.
Additional file 3: Sequence and structural variation in the coding,
intronic and flanking sequences of the equine MSTN gene.
Sequences are provided for the + strand.
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